Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (71-80 of 304) with videos related to

Pageof 31
Sort By:
Clinical Endocrinology|November 1, 1995
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosisR Howell, M Dowsett, N King, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Oestradiol synthesis from oestrone in malignant breast epithelial cells: studies on a high affinity, 80 kDa form of oestradiol dehydrogenaseC J Newton, A Butta, J Nicholls, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian womenM Dowsett, K Donaldson, M Tsuboi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretionM Dowsett, A Mehta, B M Cantwell, et al.
British Journal of Cancer|January 1, 1989
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancerA L Harris, J Carmichael, B M Cantwell, et al.
Annals of Clinical Biochemistry|May 1, 1986
Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancerM Dowsett, R M Murray, P Pitt, et al.
International Journal of Cancer|August 7, 1997
Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancerX Zhu, A A Daffada, C M Chan, et al.
Clinical Endocrinology|May 1, 1990
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patientsM Dowsett, R C Stein, A Mehta, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancerA L Harris, M Dowsett, I E Smith, et al.
Journal of Molecular Endocrinology|December 1, 1994
Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reactionA A Daffada, S R Johnston, J Nicholls, et al.
Pageof 31

Showing results (71-80 of 304) with videos related to

Sort By:
Pageof 31
Clinical Endocrinology|November 1, 1995
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosisR Howell, M Dowsett, N King, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Oestradiol synthesis from oestrone in malignant breast epithelial cells: studies on a high affinity, 80 kDa form of oestradiol dehydrogenaseC J Newton, A Butta, J Nicholls, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian womenM Dowsett, K Donaldson, M Tsuboi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretionM Dowsett, A Mehta, B M Cantwell, et al.
British Journal of Cancer|January 1, 1989
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancerA L Harris, J Carmichael, B M Cantwell, et al.
Annals of Clinical Biochemistry|May 1, 1986
Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancerM Dowsett, R M Murray, P Pitt, et al.
International Journal of Cancer|August 7, 1997
Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancerX Zhu, A A Daffada, C M Chan, et al.
Clinical Endocrinology|May 1, 1990
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patientsM Dowsett, R C Stein, A Mehta, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancerA L Harris, M Dowsett, I E Smith, et al.
Journal of Molecular Endocrinology|December 1, 1994
Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reactionA A Daffada, S R Johnston, J Nicholls, et al.
Pageof 31